Polaryx Therapeutics is working to bring patient-friendly treatments to people with ultra-rare genetic disorders known as neuronal ceroid lipofuscinoses (NCLs), the most common of which is Batten ...

Population is 57,000 and a service area of over 100,000. The 7th International Congress on Neuronal Ceroid Lipofuscinoses (NCLs) will be held June 13-16, 1998 in Dallas, Texas, at the University ...

NICE had been assessing Brineura (cerliponase alfa) for children with neuronal ceroid lipofuscinosis type 2 (CLN2), a rare inherited condition affecting between one and six babies each year in the UK.

Kriscenski-Perry, E, AD Kovacs, and DA Pearce. "Seizure Susceptibility, Phenotype, and Resultant Growth Delay in the nclf and mnd Mouse Models of Neuronal Ceroid Lipofuscinoses." The Journal of Child ...

Galvin, N., Vogler, C., Levy, B., Kovacs, A., Griffey, M., Sands, M.S. A murine model of infantile neuronal ceroid lipofuscinosis - Ultrastructural evaluation of ...